Skin Rashes Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Rashes, including details on dermatitis, itches, creams, medication, treatment.

Volume 2 (2005), Issue 8 (August)

1. Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.
   Neuro-oncol, 7(3): 246-53. [Abstract] [Full-text]
2. Comparative genetic characterization of Porcine Circovirus type 2 samples from German wild boar populations.
   Vet Microbiol, 109(3): 169-77. [Abstract] [Full-text]
3. DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells.
   J Dermatol Sci, 39(2): 113-23. [Abstract] [Full-text]
4. Skin analysis to determine causative agent in dermal exposure to petroleum products.
   J Chromatogr B Analyt Technol Biomed Life Sci, 823(1): 53-9. [Abstract] [Full-text]
5. Noncalcemic actions of vitamin D receptor ligands.
   Endocr Rev, 26(5): 662-87. [Abstract] [Full-text]
6. The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis.
   Arch Pediatr Adolesc Med, 159(8): 745-50. [Abstract] [Full-text]
7. Toilet seat contact dermatitis.
   Pediatr Dermatol, 22(4): 344-5. [Abstract] [Full-text]
8. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients.
   Allergy, 60(9): 1152-6. [Abstract] [Full-text]
9. Interleukin-10 haplotype associated with total serum IgE in atopic dermatitis patients.
   Allergy, 60(9): 1146-51. [Abstract] [Full-text]
10. Liposuction and extravasation injuries in ICU.
    Br J Anaesth, 95(3): 355-7. [Abstract] [Full-text]
11. FDA drug approval summary: erlotinib (Tarceva) tablets.
    Oncologist, 10(7): 461-6. [Abstract] [Full-text]
12. Novel application of the masson-fontana stain for demonstrating Malassezia species melanin-like pigment production in vitro and in clinical specimens.
    J Clin Microbiol, 43(8): 4147-51. [Abstract] [Full-text]
13. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
    Eye, 19(8): 846-53. [Abstract] [Full-text]
14. A critical review of the inter-relationship between skin vulnerability and urinary incontinence and related nursing intervention.
    Int J Nurs Stud, 42(7): 823-35. [Abstract] [Full-text]
15. Increased incidence of latex allergy in children with allergic diseases in Japan.
    Public Health. [Abstract] [Full-text]
16. Malassezia Baillon, emerging clinical yeasts.
    FEMS Yeast Res. [Abstract] [Full-text]
17. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.
    J Allergy Clin Immunol, 116(2): 390-6. [Abstract] [Full-text]
18. Cardiac Thrombus in Omenn Syndrome.
    Pediatr Cardiol. [Abstract] [Full-text]
19. Hereditary mucoepithelial dysplasia: clinical, ultrastructural and genetic study of eight patients and literature review.
    Br J Dermatol, 153(2): 310-8. [Abstract] [Full-text]
20. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Dermatology, 211(2): 174-87. [Abstract] [Full-text]
21. Head and neck atopic dermatitis and malassezia-furfur-specific IgE antibodies.
    Dermatology, 211(2): 107-13. [Abstract] [Full-text]
22. Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.
    Br J Dermatol, 153(2): 417-23. [Abstract] [Full-text]
23. The development of a preference-based measure of health in children with atopic dermatitis.
    Br J Dermatol, 153(2): 372-7. [Abstract] [Full-text]
24. Analysis of para-phenylenediamine allergic patients in relation to strength of patch test reaction.
    Br J Dermatol, 153(2): 364-7. [Abstract] [Full-text]
25. Serum antidiuretic hormone is elevated in relation to the increase in average total body transepidermal water loss in severe atopic dermatitis.
    Br J Dermatol, 153(2): 359-63. [Abstract] [Full-text]
26. A comparison between criteria for diagnosing atopic eczema in infants.
    Br J Dermatol, 153(2): 352-8. [Abstract] [Full-text]
27. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
    Br J Dermatol, 153(2): 274-81. [Abstract] [Full-text]
28. Toxic epidermal necrolysis: current evidence, practical management and future directions.
    Br J Dermatol, 153(2): 241-53. [Abstract] [Full-text]
29. Plasma levels of polyunsaturated fatty acids in children with atopic dermatitis and in atopic and nonatopic controls.
    Wien Klin Wochenschr, 117(13): 485-91. [Abstract] [Full-text]
30. A survey of traditional Chinese medicine use in children with atopic dermatitis attending a paediatric dermatology clinic.
    J Dermatolog Treat, 16(3): 154-7. [Abstract] [Full-text]
31. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
    J Dermatolog Treat, 16(3): 149-53. [Abstract] [Full-text]
32. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    J Dermatolog Treat, 16(3): 142-8. [Abstract] [Full-text]
33. CD44, but not l-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis.
    Exp Dermatol, 14(9): 700-8. [Abstract] [Full-text]
34. Identification of differentially expressed genes in psoriasis using expression profiling approaches.
    Exp Dermatol, 14(9): 667-74. [Abstract] [Full-text]
35. Experimental approaches to lymphocyte migration in dermatology in vitro and in vivo.
    Exp Dermatol, 14(9): 641-66. [Abstract] [Full-text]
36. Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM).
    J Invest Dermatol, 125(2): 353-63. [Abstract] [Full-text]
37. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin.
    J Exp Med, 202(4): 541-9. [Abstract] [Full-text]
38. CTLA-4 expression in T cells of patients with atopic dermatitis.
    Pediatr Allergy Immunol, 16(5): 422-7. [Abstract] [Full-text]
39. A case of allergic contact dermatitis from propylene glycol in an ultrasonic gel, sensitized at a leakage skin injury due to transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Int J Dermatol, 44(8): 681-3. [Abstract] [Full-text]
40. Skin disease patterns in Hormozgan, Iran.
    Int J Dermatol, 44(8): 641-5. [Abstract] [Full-text]
41. Thymoma-associated exfoliative dermatitis in a rabbit.
    Vet Dermatol, 16(4): 281-4. [Abstract] [Full-text]
42. Bilateral ear canal neoplasia in three dogs.
    Vet Dermatol, 16(4): 276-80. [Abstract] [Full-text]
43. Humoral measurement of type-1 hypersensitivity reactions to a commercial Malassezia allergen.
    Vet Dermatol, 16(4): 261-8. [Abstract] [Full-text]
44. Prevalence of the group 1 Dermatophagoides allergens Der p 1 and Der f 1 in homes with no dogs, healthy dogs and Dermatophagoides-sensitized atopic dogs in Liverpool.
    Vet Dermatol, 16(4): 253-60. [Abstract] [Full-text]
45. Clinical, histopathological and immunological characteristics of exfoliative cutaneous lupus erythematosus in 25 German short-haired pointers.
    Vet Dermatol, 16(4): 239-52. [Abstract] [Full-text]
46. Hypersensitivity syndrome and pure red cell aplasia following allopurinol therapy in a patient with chronic kidney disease.
    Ann Pharmacother, 39(9): 1552-6. [Abstract] [Full-text]
47. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
    Eur J Pharmacol, 518(2): 133-9. [Abstract] [Full-text]
48. Much atopy about the skin: genome-wide molecular analysis of atopic eczema.
    Int Arch Allergy Immunol, 137(4): 319-25. [Abstract] [Full-text]
49. BCG immunization at birth and atopic diseases in a homogeneous population of Spanish schoolchildren.
    Int Arch Allergy Immunol, 137(4): 303-9. [Abstract] [Full-text]
50. A phase I trial of alfimeprase for peripheral arterial thrombolysis.
    J Vasc Interv Radiol, 16(8): 1075-83. [Abstract] [Full-text]
51. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo.
    Chem Immunol Allergy, 87: 179-97. [Abstract] [Full-text]
52. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
    J Clin Oncol, 23(24): 5578-87. [Abstract] [Full-text]
53. A randomised controlled intervention study on prevention of work related skin problems among gut cleaners in swine slaughterhouses.
    Occup Environ Med, 62(9): 642-9. [Abstract] [Full-text]
54. An assessment of dermal exposure to semi-synthetic metal working fluids by different methods to group workers for an epidemiological study on dermatitis.
    Occup Environ Med, 62(9): 633-41. [Abstract] [Full-text]
55. Non-enzymatic glutathione reactivity and in vitro toxicity: A non-animal approach to skin sensitization.
    Toxicol In Vitro. [Abstract] [Full-text]
56. Massage therapy for skin conditions in young children.
    Dermatol Clin, 23(4): 717-21. [Abstract] [Full-text]
57. Psychoneuroimmunodermatology of atopic dermatitis: from empiric data to the evolutionary hypothesis.
    Dermatol Clin, 23(4): 695-701. [Abstract] [Full-text]
58. Psychologic trauma, posttraumatic stress disorder, and dermatology.
    Dermatol Clin, 23(4): 649-56. [Abstract] [Full-text]
59. The emotional impact of chronic and disabling skin disease: a psychoanalytic perspective.
    Dermatol Clin, 23(4): 619-27. [Abstract] [Full-text]
60. Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000.
    J Am Acad Dermatol, 53(3): 416-21. [Abstract] [Full-text]
61. Risk of skin reactions when using ibuprofen-based medicines.
    Expert Opin Drug Saf, 4(5): 837-48. [Abstract] [Full-text]
62. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity.
    Gene Ther, 12(17): 1294-304. [Abstract] [Full-text]
63. Effects of probiotics on atopic dermatitis: a randomised controlled trial.
    Arch Dis Child, 90(9): 892-7. [Abstract] [Full-text]
64. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity.
    J Invest Dermatol, 125(3): 510-20. [Abstract] [Full-text]
65. Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model.
    J Invest Dermatol, 125(3): 473-81. [Abstract] [Full-text]
66. The risk of cancer among patients previously hospitalized for atopic dermatitis.
    J Invest Dermatol, 125(3): 445-9. [Abstract] [Full-text]
67. Measurement of sunscreen immune protection factors in humans: a consensus paper.
    J Invest Dermatol, 125(3): 403-9. [Abstract] [Full-text]
68. Investigation of reactions to dental materials.
    Br J Dermatol, 153(3): 479-85. [Abstract] [Full-text]
69. Mucosal disease series. Number IV. Erythema multiforme.
    Oral Dis, 11(5): 261-7. [Abstract] [Full-text]
70. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis.
    Clin Exp Allergy, 35(8): 1088-95. [Abstract] [Full-text]
71. Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study.
    Clin Exp Allergy, 35(8): 1014-21. [Abstract] [Full-text]
72. CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.
    Cancer, 104(5): 1045-8. [Abstract] [Full-text]
73. Risk factors for digital dermatitis in dairy cows kept in cubicle houses in The Netherlands.
    Prev Vet Med, 71(1): 11-21. [Abstract] [Full-text]
74. Risk factors for interdigital dermatitis and heel erosion in dairy cows kept in cubicle houses in The Netherlands.
    Prev Vet Med, 71(1): 23-34. [Abstract] [Full-text]
75. Contact dermatitis due to clarifying cream.
    Contact Dermatitis, 53(3): 174-5. [Abstract] [Full-text]
76. Common contact sensitizers in the Czech Republic. Patch test results in 12,058 patients with suspected contact dermatitis*.
    Contact Dermatitis, 53(3): 162-6. [Abstract] [Full-text]
77. Allergic contact dermatitis associated with reactive dyes in a dark garment: a case report.
    Contact Dermatitis, 53(3): 150-4. [Abstract] [Full-text]
78. The European standard series in 9 European countries, 2002/2003 -- first results of the European Surveillance System on Contact Allergies.
    Contact Dermatitis, 53(3): 136-45. [Abstract] [Full-text]
79. DNA damage and TNFalpha cytokine production in hairdressers with contact dermatitis.
    Contact Dermatitis, 53(3): 125-9. [Abstract] [Full-text]
80. Sugar micro needles as transdermic drug delivery system.
    Biomed Microdevices, 7(3): 185-8. [Abstract] [Full-text]
81. Successful Treatment of Poison Oak Dermatitis Treated with Grindelia spp. (Gumweed).
    J Altern Complement Med, 11(4): 709-10. [Abstract] [Full-text]
82. The genetics of atopic dermatitis: recent findings and future options.
    J Mol Med, 83(9): 682-92. [Abstract] [Full-text]

© 2004-2008 Skin Rashes Research Today. All Rights Reserved.